Liver Tumor Segmentation on LiTS (5-fold cross-validation)
59.77DSClabel-free
Evaluation Results
| Method | Links | ||
|---|---|---|---|
| label-freetumors=synt, architecture=U-Net, labeled / unlabeled CTs=0 / 116, validation_strategy=5-fold cross-validation2023.03 | 59.77 | 61.29 | |
| fully-supervisedtumors=real, architecture=U-Net, labeled / unlabeled CTs=101 / 0, validation_strategy=5-fold cross-validation2023.03 | 57.51 | 58.04 | |
| Yao et al.tumors=synt, architecture=U-Net, labeled / unlabeled CTs=0 / 116, validation_strategy=5-fold cross-validation2023.03 | 32.79 | 31.28 | |
| VAEtumors=none, architecture=Customized, labeled / unlabeled CTs=0 / 116, validation_strategy=5-fold cross-validation2023.03 | 24.63 | 23.63 | |
| f-AnoGANtumors=none, architecture=Customized, labeled / unlabeled CTs=0 / 116, validation_strategy=5-fold cross-validation2023.03 | 19 | 16.94 | |
| PatchCoretumors=none, architecture=Wide-Resnet50-2, labeled / unlabeled CTs=0 / 116, validation_strategy=5-fold cross-validation2023.03 | 15.97 | 16.43 |